70 related articles for article (PubMed ID: 24754681)
1. An NRAS mutation in a case of Erdheim-Chester disease.
Aitken SJ; Presneau N; Tirabosco R; Amary MF; O'Donnell P; Flanagan AM
Histopathology; 2015 Jan; 66(2):316-9. PubMed ID: 24754681
[No Abstract] [Full Text] [Related]
2. Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib.
Riancho JA; Hernández JL; González-Vela C; López-Sundh AE; González-Lopez MA; Gomez de la Fuente F; Quirce R; Diamond EL
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895147
[TBL] [Abstract][Full Text] [Related]
3. Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations.
Prabhakaran N; Jour G; Balar A; Ward N
Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
[TBL] [Abstract][Full Text] [Related]
5. Identifying mutant pathways in the histiocytoses.
Prince HM
Blood; 2014 Nov; 124(19):2901-3. PubMed ID: 25377560
[TBL] [Abstract][Full Text] [Related]
6. Detection of an NRAS mutation in Erdheim-Chester disease.
Diamond EL; Abdel-Wahab O; Pentsova E; Borsu L; Chiu A; Teruya-Feldstein J; Hyman DM; Rosenblum M
Blood; 2013 Aug; 122(6):1089-91. PubMed ID: 23929840
[No Abstract] [Full Text] [Related]
7. Erdheim-Chester disease harboring the BRAF V600E mutation.
Blombery P; Wong SQ; Lade S; Prince HM
J Clin Oncol; 2012 Nov; 30(32):e331-2. PubMed ID: 23008323
[No Abstract] [Full Text] [Related]
8. BRAF mutations in Erdheim-Chester disease.
Emile JF; Charlotte F; Amoura Z; Haroche J
J Clin Oncol; 2013 Jan; 31(3):398. PubMed ID: 23248255
[No Abstract] [Full Text] [Related]
9. Erdheim-Chester Disease With Cardiovascular Involvement and BRAF V600E Mutation.
Okamura K; Suematsu Y; Morizumi S; Kawata M; Dai Y; Yamakawa M; Ono M
Circ J; 2016 Jun; 80(7):1657-9. PubMed ID: 27296272
[No Abstract] [Full Text] [Related]
10. Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.
Cohen-Aubart F; Emile JF; Carrat F; Helias-Rodzewicz Z; Taly V; Charlotte F; Cluzel P; Donadieu J; Idbaih A; Barete S; Amoura Z; Haroche J
Am J Hematol; 2018 May; 93(5):E114-E117. PubMed ID: 29396850
[No Abstract] [Full Text] [Related]
11. KIT, NRAS, and BRAF mutations in nail apparatus melanoma.
Dika E; Altimari A; Patrizi A; Gruppioni E; Fiorentino M; Piraccini BM; Misciali C; Barisani A; Fanti PA
Pigment Cell Melanoma Res; 2013 Sep; 26(5):758-60. PubMed ID: 23782496
[No Abstract] [Full Text] [Related]
12. Prevalence of BRAF and NRAS mutations in fast-growing melanomas.
Nagore E; Hacker E; Martorell-Calatayud A; Traves V; Guillen C; Hayward NK; Whiteman D
Pigment Cell Melanoma Res; 2013 May; 26(3):429-31. PubMed ID: 23448684
[No Abstract] [Full Text] [Related]
13. Detection of anti-neutrophil cytoplasmic and antinuclear autoantibodies favouring misdiagnoses in 5 cases of Erdheim-Chester disease.
Özden F; Schinke S; Thorns C; Eckey T; Dalhoff K; Münte TF; Tronnier V; Humrich JY; Riemekasten G; Lamprecht P
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):176. PubMed ID: 29652657
[No Abstract] [Full Text] [Related]
14. [Mutation pedigree and treatment selection of Erdheim-Chester disease].
Lang M; Zhou DB; Cao XX
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):876-880. PubMed ID: 38049347
[No Abstract] [Full Text] [Related]
15. Erdheim-Chester disease involving the breast--a rare but important differential diagnosis.
Guo S; Yan Q; Rohr J; Wang Y; Fan L; Wang Z
Hum Pathol; 2015 Jan; 46(1):159-64. PubMed ID: 25454479
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.
Ilie M; Long-Mira E; Funck-Brentano E; Lassalle S; Butori C; Lespinet-Fabre V; Bordone O; Gay A; Zahaf K; Poissonnet G; Lacour JP; Bahadoran P; Ballotti R; Gros A; Dutriaux C; Saiag P; Merlio JP; Vergier B; Emile JF; Hofman V; Hofman P
J Am Acad Dermatol; 2015 May; 72(5):786-93. PubMed ID: 25659223
[TBL] [Abstract][Full Text] [Related]
17. NRAS mutations in de novo acute leukemia: prevalence and clinical significance.
Dunna NR; Vuree S; Anuradha C; Sailaja K; Surekha D; Digumarti RR; Rao VR; Yadav SK; Reddy R; Vishnupriya S
Indian J Biochem Biophys; 2014 Jun; 51(3):207-10. PubMed ID: 25204082
[TBL] [Abstract][Full Text] [Related]
18. A postzygotic NRAS mutation in a patient with Schimmelpenning syndrome.
Kuroda Y; Ohashi I; Enomoto Y; Naruto T; Baba N; Tanaka Y; Aida N; Okamoto N; Niihori T; Aoki Y; Kurosawa K
Am J Med Genet A; 2015 Sep; 167A(9):2223-5. PubMed ID: 25914220
[No Abstract] [Full Text] [Related]
19. [An ophthalmologic diagnostic error leading to a rare systemic diagnosis: Erdheim-Chester disease].
Gilles M; Alberti N; Seguy C; Leger F; Frulio N; Pechmeja J; Longueville E; Korobelnik JF
J Fr Ophtalmol; 2014 May; 37(5):377-80. PubMed ID: 24674299
[TBL] [Abstract][Full Text] [Related]
20. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.
van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA
Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
